TMEM67 and prostate cancer: Elevated cellular levels of TACC3 were shown to induce loss of primary cilia through Aurora A induction and disruption of the transmembrane protein 67 (TMEM67)-filamin A complex [260,261], and promoted oncogenic transformation and shortened survival of the patients with prostate cancer [262].